Sugarloaf Wealth Management, LLC Sorrento Therapeutics, Inc. Transaction History

Sugarloaf Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$0.74 - $1.83 $1,517 - $3,751	2,050 Added 75.93%	4,750 $4,000
Q3 2022 Oct 11, 2022	SELL	$1.51 - $2.88 $1,208 - $2,304	-800 Reduced 22.86%	2,700 $5,000
Q2 2022 Jul 12, 2022	BUY	$1.24 - $2.33 $3,100 - $5,825	2,500 Added 250.0%	3,500 $7,000
Q1 2022 Apr 25, 2022	BUY	$2.0 - $4.9 $2,000 - $4,900	1,000 New	1,000 $2,000
Q1 2021 Apr 19, 2021	SELL	$7.03 - $16.51 $14,060 - $33,020	-2,000 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$5.76 - $11.95 $9,648 - $20,016	1,675 Added 515.38%	2,000 $14,000
Q3 2020 Nov 03, 2020	BUY	$6.17 - $18.82 $2,005 - $6,116	325 New	325 $4,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.